CHIMERIC THERAPEUTICS LIMITED (CHM)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CHM - CHIMERIC THERAPEUTICS LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : Materials
Debt/EBITDA: N/A
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.025

28 Feb
2024

0.000

OPEN

$0.03

0.000

HIGH

$0.03

801,126

LOW

$0.03

FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 202120222023
EPS Basic xxxxxx-6.0
DPS All xxxxxx0.0
Sales/Revenue xxxxxx-
Book Value Per Share xxxxxx1.1
Net Operating Cash Flow xxxxxx-16.3 M
Net Profit Margin xxxxxx-

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023
Return on Capital Employed xxxxxx-165.25 %
Return on Invested Capital xxxxxx-165.25 %
Return on Assets xxxxxx-90.53 %
Return on Equity xxxxxx-165.25 %
Return on Total Capital xxxxxx-188.01 %
Free Cash Flow ex dividends xxxxxx-16.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023
Short-Term Debt xxxxxx-
Long Term Debt xxxxxx-
Total Debt xxxxxx-
Goodwill - Gross xxxxxx-
Cash & Equivalents - Generic xxxxxx5 M
Price To Book Value xxxxxx3.40

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023
Capex xxxxxx0.1 M
Capex % of Sales xxxxxx-
Cost of Goods Sold xxxxxx1 M
Selling, General & Admin. Exp & Other xxxxxx29 M
Research & Development xxxxxx13 M
Investments - Total xxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

CHM STOCK CHART